-
The bill, approved by the Senate after changes by the House, would ease restrictions on doctors prescribing controlled substances through telehealth.
-
The bill in part would permit physicians to use telemedicine when issuing a renewal of certain drugs that are classified as controlled substances, including ketamine, anabolic steroids and codeine.
-
The measure approved by the House Health & Human Services Committee, would allow physicians to prescribe certain drugs, including anabolic steroids and barbiturates, during telehealth consultations.
-
A ban on using telemedicine to prescribe controlled medications was suspended in the pandemic. That's allowed many to seek opioid addiction treatment, but some worry about potential for abuse.
-
Medicare billing codes for audio-only follow-up check-ins are leadng to new reimbursement battles.
-
State rules were temporarily loosened in 2020 to help patients get care outside a doctor's office. But is telehealth by phone safe and effective? State legislatures and insurers must soon decide.
-
An NPR poll finds that while a large majority of people using telehealth during the pandemic were satisfied, nearly two-thirds prefer in-person visits. That may foretell telehealth's future.
-
New, often lower-cost plans capitalize on the convenience of telemedicine and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.
-
Televisits took off during the worst days of the pandemic, but states are rolling back the temporary rules that facilitated them. That’s adding fuel to debates about states’ authority over medical licensing.
-
Gov. Ron DeSantis let an executive order declaring a public health emergency expire Saturday, and with it many regulatory flexibilities providers received during the pandemic including those related to telehealth.